# DOPAMINE HYDROCHLORIDE
> **ANDA207707** · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA INTL PHARMS · Approved 2018-04-11
## Drug
- **FDA Application Number:** ANDA207707
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DOPAMINE HYDROCHLORIDE
- **Generic name:** DOPAMINE HYDROCHLORIDE
- **Active ingredients:** DOPAMINE HYDROCHLORIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** HIKMA INTL PHARMS
- **Manufacturer:** Hikma Pharmaceuticals USA Inc.
- **First approval:** 2018-04-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207707)
---
*AI Analytics · CC0 1.0*